GCTK vs JAZZ · P/E 0.1, $4.1M cap vs P/E 1988, rev $2.28B
GlucoTrack Inc (GCTK) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
GCTK does not have a complete income-statement cache yet.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GCTK and JAZZ stock pages for the full models.
Not investment advice.